Audiologists in Cherry Hill, NJ Accepting Medicare

6 Audiologists found. Showing 1 - 6

Dr. Nicholete Michelle Davis, AU.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1924 Route 70 E, Cherry Hill, NJ 08003 Phone: 856-424-9200

Ms. Deborah J Burke, CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1020 Kings Hwy N, Suite 201, Cherry Hill, NJ 08034 Phone: 856-667-1575    Fax: 856-667-3020

Ms. Elyse L. Ockner, M.A., CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 401 Cooper Landing Rd, Suite C-7, Cherry Hill, NJ 08002 Phone: 856-667-5110    Fax: 856-667-5119

Steven E Berman, PHD Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1401 Route 70 E Ste 27, Sj Medical Center, Cherry Hill, NJ 08034 Phone: 856-795-5502    Fax: 856-751-0777

Katherine Proud Audiologist Medicare: Accepting Medicare Assignments Practice Location: 500 Route 38, Cherry Hill, NJ 08002 Phone: 856-661-1681

Dr. Melanie C Holman, AU.D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1924 Route 70 E, Cherry Hill, NJ 08003 Phone: 856-424-9200    Fax: 856-424-9245

News Archive

Study finds a link between chronotype and shift worker's sleep

Getting enough sleep can be a real challenge for shift workers affecting their overall health. But what role does being an early bird or night owl play in getting good rest? Researchers from McGill University find a link between chronotype and amount of sleep shift workers can get with their irregular schedules.

Scientist suggests breaking tangled mucus barrier can help treat cancer

Measuring the mechanical strength of cancer cell mucus layers provides clues about better ways to treat cancer, and also suggests why some cancer cells are more resistant to drugs than others, according to Kai-tak Wan, associate professor of engineering at Northeastern University, Boston, Mass.

Synthetic Biologics announces positive results from first SYN-004 Phase 2a study for prevention of CDI, AAD

Synthetic Biologics, Inc.), a clinical stage company focused on developing therapeutics to protect the gut microbiome while targeting pathogen specific diseases, announced positive topline results from the first Phase 2a study of SYN-004, the Company's candidate designed to protect the gut microbiome from the unintended effects of certain commonly used intravenous (IV) beta-lactam antibiotics for the prevention C. difficile infection (CDI) and antibiotic-associated diarrhea (AAD).

Salk scientist receives NIH Pioneer Award to support innovative biomedical research

Salk Professor Juan Carlos Izpisua Belmonte has been awarded a 2016 National Institutes of Health Pioneer Award, a highly coveted grant that supports the most innovative biomedical research, for his work in stem cell biology and regeneration.

Patient satisfaction not best indication of quality of care

The argument that the "best way to improve the quality and restrain the cost of health care is to make the market for health care more like the market for everything else" is based on the erroneous "belief that health care is - in most respects - like any other product," columnist David Wessel writes in a Wall Street Journal opinion piece.

Read more Medical News

› Verified 2 days ago